DexCom Other Income (Expense) decreased by 19.8% to $14.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.1%, from $20.60M to $14.20M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 110.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $900.00K | -$1.70M | -$8.30M | -$800.00K | $3.00M | -$1.30M | -$1.30M | $17.30M | $31.20M | $34.90M | $29.30M | $31.40M | $29.80M | $25.40M | $22.40M | $20.60M | $28.50M | $109.80M | $17.70M | $14.20M |
| QoQ Change | — | -288.9% | -388.2% | +90.4% | +475.0% | -143.3% | +0.0% | >999% | +80.3% | +11.9% | -16.0% | +7.2% | -5.1% | -14.8% | -11.8% | -8.0% | +38.3% | +285.3% | -83.9% | -19.8% |
| YoY Change | — | — | — | — | +233.3% | +23.5% | +84.3% | >999% | +940.0% | >999% | >999% | +81.5% | -4.5% | -27.2% | -23.5% | -34.4% | -4.4% | +332.3% | -21.0% | -31.1% |